US 9624496
Modulation of apolipoprotein C-III expression
granted A61KA61K38/00A61P
Quick answer
US patent 9624496 (Modulation of apolipoprotein C-III expression) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/00, A61P, A61P3/00, A61P3/04